{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:02:26Z","timestamp":1787313746033,"version":"build-2736575974"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"IBSA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s40122-023-00559-1","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T07:03:01Z","timestamp":1698908581000},"page":"1-22","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Glycosaminoglycan Replacement Therapy with Intravesical Instillations of Combined Hyaluronic Acid and Chondroitin Sulfate in Patients with Recurrent Cystitis, Post-radiation Cystitis and Bladder Pain Syndrome: A Narrative Review"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7664-9816","authenticated-orcid":false,"given":"S\u0142awomir","family":"Poletajew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8633-2855","authenticated-orcid":false,"given":"Magdalena M.","family":"Brz\u00f3zka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1727-2283","authenticated-orcid":false,"given":"Wojciech","family":"Krajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8387-1474","authenticated-orcid":false,"given":"Hubert","family":"Kamecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4783-7273","authenticated-orcid":false,"given":"\u0141ukasz","family":"Nyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2551-0296","authenticated-orcid":false,"given":"Piotr","family":"Kryst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"issue":"1","key":"559_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/nau.22256","volume":"32","author":"H Madersbacher","year":"2013","unstructured":"Madersbacher H, van Ophoven A, van Kerrebroeck PE. GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans\u2014a review. Neurourol Urodyn. 2013;32(1):9\u201318.","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"559_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/1756287215621234","volume":"8","author":"M Lazzeri","year":"2016","unstructured":"Lazzeri M, Hurle R, Casale P, Buffi N, Lughezzani G, Fiorini G, Peschechera R, Pasini L, Zandegiacomo S, Benetti A, Taverna G, Guazzoni G, Barbagli G. Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence. Ther Adv Urol. 2016;8(2):91\u20139.","journal-title":"Ther Adv Urol"},{"issue":"5","key":"559_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/1756287211418723","volume":"3","author":"R Damiano","year":"2011","unstructured":"Damiano R, Cicione A. The role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease. Ther Adv Urol. 2011;3(5):223\u201332.","journal-title":"Ther Adv Urol"},{"key":"559_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/978-3-642-16499-6_9","volume":"202","author":"AJ Kanai","year":"2011","unstructured":"Kanai AJ. Afferent mechanism in the urinary tract. Handb Exp Pharmacol. 2011;202:171\u2013205.","journal-title":"Handb Exp Pharmacol"},{"key":"559_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/978-3-642-16499-6_19","volume":"202","author":"L Arms","year":"2011","unstructured":"Arms L, Vizzard MA. Neuropeptides in lower urinary tract function. Handb Exp Pharmacol. 2011;202:395\u2013423.","journal-title":"Handb Exp Pharmacol"},{"issue":"6","key":"559_CR6","first-page":"493","volume":"171","author":"JD Lilly","year":"1990","unstructured":"Lilly JD, Parsons CL. Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg Gynecol Obstet. 1990;171(6):493\u20136.","journal-title":"Surg Gynecol Obstet"},{"issue":"Suppl 3","key":"559_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1464-410X.2008.07493.x","volume":"101","author":"P Geppetti","year":"2008","unstructured":"Geppetti P, Nassini R, Materazzi S, Benemei S. The concept of neurogenic inflammation. BJU Int. 2008;101(Suppl 3):2\u20136.","journal-title":"BJU Int"},{"issue":"113 Suppl 1A","key":"559_CR8","doi-asserted-by":"publisher","first-page":"5S","DOI":"10.1016\/S0002-9343(02)01054-9","volume":"8","author":"B Foxman","year":"2002","unstructured":"Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;8(113 Suppl 1A):5S-13S.","journal-title":"Am J Med"},{"issue":"1","key":"559_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/clinids\/22.1.91","volume":"22","author":"R Ik\u00e4heimo","year":"1996","unstructured":"Ik\u00e4heimo R, Siitonen A, Heiskanen T, K\u00e4rkk\u00e4inen U, Kuosmanen P, Lipponen P, M\u00e4kel\u00e4 PH. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis. 1996;22(1):91\u20139.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"559_CR10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrurol.2010.190","volume":"7","author":"B Foxman","year":"2010","unstructured":"Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7(12):653\u201360.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"559_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.eursup.2016.04.007","volume":"15","author":"W Vahlensieck","year":"2016","unstructured":"Vahlensieck W, Perepanova T, Bjerklund Johansen TE, Tenke P, Naber KG, Wagenlehner FE. Management of Uncomplicated Recurrent Urinary Tract Infections. Eur Urol Suppl. 2016;15(4):95\u2013101.","journal-title":"Eur Urol Suppl"},{"issue":"2","key":"559_CR12","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.1093\/clinids\/9.Supplement_2.S195","volume":"9","author":"TA Stamey","year":"1987","unstructured":"Stamey TA. Recurrent urinary tract infections in female patients: an overview of management and treatment. Rev Infect Dis. 1987;9(2):S195-210.","journal-title":"Rev Infect Dis"},{"issue":"3","key":"559_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/00325481.1987.11699724","volume":"81","author":"AJ Schaeffer","year":"1987","unstructured":"Schaeffer AJ. Recurrent urinary tract infections in women. Pathogenesis Manag Postgrad Med. 1987;81(3):51\u20138.","journal-title":"Pathogenesis Manag Postgrad Med"},{"issue":"4","key":"559_CR14","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0094-0143(21)00271-8","volume":"13","author":"JE Fowler Jr","year":"1986","unstructured":"Fowler JE Jr. Urinary tract infections in women. Urol Clin North Am. 1986;13(4):673\u201383.","journal-title":"Urol Clin North Am"},{"issue":"12","key":"559_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040329","volume":"4","author":"DA Rosen","year":"2007","unstructured":"Rosen DA, Hooton TM, Stamm WE, Humphrey PA, Hultgren SJ. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med. 2007;4(12): e329.","journal-title":"PLoS Med"},{"issue":"5","key":"559_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1078-1439(00)00074-0","volume":"5","author":"MM Poggi","year":"2000","unstructured":"Poggi MM, Johnstone PA, Conner RJ. Glycosaminoglycan content of human bladders. A method of analysis using cold-cup biopsies. Urol Oncol. 2000;5(5):234\u20137.","journal-title":"Urol Oncol"},{"issue":"5A Suppl","key":"559_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0090-4295(97)00183-0","volume":"49","author":"A Morales","year":"1997","unstructured":"Morales A, Emerson L, Nickel JC. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. Urology. 1997;49(5A Suppl):111\u20133.","journal-title":"Urology"},{"issue":"5A Suppl","key":"559_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0090-4295(97)00180-5","volume":"49","author":"CL Parsons","year":"1997","unstructured":"Parsons CL. Epithelial coating techniques in the treatment of interstitial cystitis. Urology. 1997;49(5A Suppl):100\u20134.","journal-title":"Urology"},{"issue":"8","key":"559_CR19","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/iju.12430","volume":"21","author":"A Cicione","year":"2014","unstructured":"Cicione A, Cantiello F, Ucciero G, Salonia A, Madeo I, Bava I, Aliberti A, Damiano R. Restoring the glycosaminoglycans layer in recurrent cystitis: experimental and clinical foundations. Int J Urol. 2014;21(8):763\u20138.","journal-title":"Int J Urol"},{"issue":"4","key":"559_CR20","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1021\/acsinfecdis.3c00027","volume":"9","author":"ML Neugent","year":"2023","unstructured":"Neugent ML, Hulyalkar NV, Kumar A, Xing C, Zimmern PE, Shulaev V, De Nisco NJ. Urinary Glycosaminoglycans Are Associated with Recurrent UTI and Urobiome Ecology in Postmenopausal Women. ACS Infect Dis. 2023;9(4):1022\u201332.","journal-title":"ACS Infect Dis"},{"issue":"5","key":"559_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.eururo.2020.06.032","volume":"78","author":"KG Naber","year":"2020","unstructured":"Naber KG, Bonkat G, Wagenlehner FME. The EAU and AUA\/CUA\/SUFU Guidelines on Recurrent Urinary Tract Infections: What is the Difference? Eur Urol. 2020;78(5):645\u20136.","journal-title":"Eur Urol"},{"issue":"12","key":"559_CR22","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1111\/j.1442-2042.2012.03109.x","volume":"19","author":"S Tasdemir","year":"2012","unstructured":"Tasdemir S, Tasdemir C, Vardi N, Yakupogullari Y, Duman Y, Parlakpinar H, Sagir M, Acet A. Intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: assessment of protective effects in a rat model. Int J Urol. 2012;19(12):1108\u201312.","journal-title":"Int J Urol"},{"issue":"4","key":"559_CR23","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.eururo.2010.12.039","volume":"59","author":"R Damiano","year":"2011","unstructured":"Damiano R, Quarto G, Bava I, Ucciero G, De Domenico R, Palumbo MI, Autorino R. Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial. Eur Urol. 2011;59(4):645\u201351.","journal-title":"Eur Urol"},{"issue":"1","key":"559_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.eururo.2011.03.031","volume":"60","author":"R Damiano","year":"2011","unstructured":"Damiano R, Quarto G, Bava I, Ucciero G, De Domenico R, Palumbo MI, Autorino R. Corrigendum to \"Prevention of Recurrent Urinary Tract Infections by Intravesical Administration of Hyaluronic Acid and Chondroitin Sulphate: A Placebo-Controlled Randomised Trial [Eur Urol 2011;59:645\u201351]. Eur Urol. 2011;60(1):193.","journal-title":"Eur Urol"},{"issue":"12","key":"559_CR25","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00192-012-1794-z","volume":"23","author":"D De Vita","year":"2012","unstructured":"De Vita D, Giordano S. Effectiveness of intravesical hyaluronic acid\/chondroitin sulfate in recurrent bacterial cystitis: a randomized study. Int Urogynecol J. 2012;23(12):1707\u201313.","journal-title":"Int Urogynecol J"},{"issue":"5","key":"559_CR26","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s10156-013-0609-6","volume":"19","author":"M Torella","year":"2013","unstructured":"Torella M, Schettino MT, Salvatore S, Serati M, De Franciscis P, Colacurci N. Intravesical therapy in recurrent cystitis: a multi-center experience. J Infect Chemother. 2013;19(5):920\u20135.","journal-title":"J Infect Chemother"},{"issue":"9\u201310","key":"559_CR27","doi-asserted-by":"publisher","first-page":"E721","DOI":"10.5489\/cuaj.1989","volume":"8","author":"A Cicione","year":"2014","unstructured":"Cicione A, Cantiello F, Ucciero G, Salonia A, Torella M, De Sio M, Autorino R, Carbone A, Romancik M, Tomaskin R, Damiano R. Intravesical treatment with highly-concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections: Results from a multicentre survey. Can Urol Assoc J. 2014;8(9\u201310):E721\u20137.","journal-title":"Can Urol Assoc J"},{"issue":"5","key":"559_CR28","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.tjog.2015.03.005","volume":"54","author":"G Gugliotta","year":"2015","unstructured":"Gugliotta G, Calagna G, Adile G, Polito S, Saitta S, Speciale P, Palomba S, Perino A, Granese R, Adile B. Is intravesical instillation of hyaluronic acid and chondroitin sulfate useful in preventing recurrent bacterial cystitis? A multicenter case control analysis. Taiwan J Obstet Gynecol. 2015;54(5):537\u201340.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"3","key":"559_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009669","volume":"6","author":"O Ciani","year":"2016","unstructured":"Ciani O, Arendsen E, Romancik M, Lunik R, Costantini E, Di Biase M, Morgia G, Fragal\u00e0 E, Roman T, Bernat M, Guazzoni G, Tarricone R, Lazzeri M. Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections: a European multicentre nested case-control study. BMJ Open. 2016;6(3): e009669.","journal-title":"BMJ Open"},{"issue":"4","key":"559_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00192-012-1957-y","volume":"24","author":"D De Vita","year":"2013","unstructured":"De Vita D, Antell H, Giordano S. Effectiveness of intravesical hyaluronic acid with or without chondroitin sulfate for recurrent bacterial cystitis in adult women: a meta-analysis. Int Urogynecol J. 2013;24(4):545\u201352.","journal-title":"Int Urogynecol J"},{"issue":"7","key":"559_CR31","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00192-017-3508-z","volume":"29","author":"JC Goddard","year":"2018","unstructured":"Goddard JC, Janssen DAW. Intravesical hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections: systematic review and meta-analysis. Int Urogynecol J. 2018;29(7):933\u201342.","journal-title":"Int Urogynecol J"},{"key":"559_CR32","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress Milan 2021. ISBN 978-94-92671-13-4."},{"key":"559_CR33","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam, the Netherlands 2022. ISBN 978-94-92671-16-5"},{"key":"559_CR34","doi-asserted-by":"crossref","unstructured":"Fall M, Baranowski AP, Elneil S, Engeler D, Hughes J, Messelink EJ, Oberpenning F, de C Williams AC; European Association of Urology. EAU guidelines on chronic pelvic pain. Eur Urol. 2010;57(1):35\u201348","DOI":"10.1016\/j.eururo.2009.08.020"},{"issue":"2","key":"559_CR35","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.juro.2011.10.040","volume":"187","author":"KS Konkle","year":"2012","unstructured":"Konkle KS, Berry SH, Elliott MN, Hilton L, Suttorp MJ, Clauw DJ, Clemens JQ. Comparison of an interstitial cystitis\/bladder pain syndrome clinical cohort with symptomatic community women from the RAND Interstitial Cystitis Epidemiology study. J Urol. 2012;187(2):508\u201312.","journal-title":"J Urol"},{"issue":"2","key":"559_CR36","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.juro.2011.03.132","volume":"186","author":"SH Berry","year":"2011","unstructured":"Berry SH, Elliott MN, Suttorp M, Bogart LM, Stoto MA, Eggers P, Nyberg L, Clemens JQ. Prevalence of symptoms of bladder pain syndrome\/interstitial cystitis among adult females in the United States. J Urol. 2011;186(2):540\u20134.","journal-title":"J Urol"},{"issue":"3","key":"559_CR37","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.tjog.2014.09.007","volume":"54","author":"XM Han","year":"2015","unstructured":"Han XM, Wu XH, Li B, Pan F, Li WC, Liu SL, Zeng FQ, Chen M. The effects of intravesical therapy with hyaluronic acid for painful bladder syndrome: Preliminary Chinese experience and systematic review. Taiwan J Obstet Gynecol. 2015;54(3):240\u20137.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"3","key":"559_CR38","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1464-410X.2010.09843.x","volume":"107","author":"CL Parsons","year":"2011","unstructured":"Parsons CL. The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis\/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain. BJU Int. 2011;107(3):370\u20135.","journal-title":"BJU Int"},{"issue":"1","key":"559_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF00182044","volume":"12","author":"RE Hurst","year":"1994","unstructured":"Hurst RE. Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract. World J Urol. 1994;12(1):3\u201310.","journal-title":"World J Urol"},{"issue":"1","key":"559_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5213\/inj.1938176.088","volume":"25","author":"YO Danacioglu","year":"2021","unstructured":"Danacioglu YO, Erol B, Ozkanli S, Yildirim A, Atis RG, Silay MS, Caskurlu T. Comparison of Intravesical Hyaluronic Acid, Chondroitin Sulfate, and Combination of Hyaluronic Acid-Chondroitin Sulfate Therapies in Animal Model of Interstitial Cystitis. Int Neurourol J. 2021;25(1):42\u201350.","journal-title":"Int Neurourol J"},{"issue":"11","key":"559_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.575043","volume":"3","author":"P Rooney","year":"2020","unstructured":"Rooney P, Ryan C, McDermott BJ, Dev K, Pandit A, Quinlan LR. Effect of Glycosaminoglycan Replacement on Markers of Interstitial Cystitis In Vitro. Front Pharmacol. 2020;3(11): 575043.","journal-title":"Front Pharmacol"},{"issue":"6","key":"559_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218475","volume":"14","author":"A Stellavato","year":"2019","unstructured":"Stellavato A, Pirozzi AVA, Diana P, Reale S, Vassallo V, Fusco A, Donnarumma G, De Rosa M, Schiraldi C. Hyaluronic acid and chondroitin sulfate, alone or in combination, efficiently counteract induced bladder cell damage and inflammation. PLoS ONE. 2019;14(6): e0218475.","journal-title":"PLoS ONE"},{"issue":"1","key":"559_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/luts.12410","volume":"14","author":"M Stavropoulos","year":"2022","unstructured":"Stavropoulos M, Thakare N, Venieris P, Liakouras C, Deliveliotis C, Chrisofos M. The use of intravesical hyaluronic acid in the management of symptomatic premenopausal women with pseudomembranous trigonitis: Are symptoms related to cystoscopy and pathological findings? Low Urin Tract Symptoms. 2022;14(1):57\u201363.","journal-title":"Low Urin Tract Symptoms"},{"issue":"8","key":"559_CR44","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.3390\/diagnostics12082009","volume":"12","author":"CJ Lin","year":"2022","unstructured":"Lin CJ, Liu CK, Hsieh HY, Chen MJ, Tsai CP. Changes in Cystoscopic Findings after Intravesical Hyaluronic Acid Instillation Therapy in Patients with Interstitial Cystitis. Diagnostics (Basel). 2022;12(8):2009.","journal-title":"Diagnostics (Basel)"},{"issue":"9","key":"559_CR45","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00192-011-1546-5","volume":"23","author":"D Porru","year":"2012","unstructured":"Porru D, Leva F, Parmigiani A, Barletta D, Choussos D, Gardella B, Dacc\u00f2 MD, Nappi RE, Allegri M, Tinelli C, Bianchi CM, Spinillo A, Rovereto B. Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome\/interstitial cystitis. Int Urogynecol J. 2012;23(9):1193\u20139.","journal-title":"Int Urogynecol J"},{"issue":"9","key":"559_CR46","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00192-012-1742-y","volume":"23","author":"M Cervigni","year":"2012","unstructured":"Cervigni M, Natale F, Nasta L, Mako A. Intravesical hyaluronic acid and chondroitin sulphate for bladder pain syndrome\/interstitial cystitis: long-term treatment results. Int Urogynecol J. 2012;23(9):1187\u201392.","journal-title":"Int Urogynecol J"},{"issue":"4","key":"559_CR47","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/1756287213490052","volume":"5","author":"C Giberti","year":"2013","unstructured":"Giberti C, Gallo F, Cortese P, Schenone M. Combined intravesical sodium hyaluronate\/chondroitin sulfate therapy for interstitial cystitis\/bladder pain syndrome: a prospective study. Ther Adv Urol. 2013;5(4):175\u20139.","journal-title":"Ther Adv Urol"},{"issue":"9\u201310","key":"559_CR48","doi-asserted-by":"publisher","first-page":"E610","DOI":"10.5489\/cuaj.2036","volume":"8","author":"O G\u00fclp\u0131nar","year":"2014","unstructured":"G\u00fclp\u0131nar O, Kay\u0131\u015f A, S\u00fcer E, G\u00f6k\u00e7e M\u0130, G\u00fc\u00e7l\u00fc AG, Ar\u0131kan N. Clinical comparision of intravesical hyaluronic acid and hyaluronic acid-chondroitin sulphate therapy for patients with bladder pain syndrome\/interstitital cystitis. Can Urol Assoc J. 2014;8(9\u201310):E610\u20134.","journal-title":"Can Urol Assoc J"},{"issue":"4","key":"559_CR49","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/nau.23091","volume":"36","author":"M Cervigni","year":"2017","unstructured":"Cervigni M, Sommariva M, Tenaglia R, Porru D, Ostardo E, Giamm\u00f2 A, Trevisan S, Frangione V, Ciani O, Tarricone R, Pappagallo GL. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome\/interstitial cystitis. Neurourol Urodyn. 2017;36(4):1178\u201386.","journal-title":"Neurourol Urodyn"},{"issue":"11","key":"559_CR50","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s00192-019-04036-2","volume":"30","author":"B Arslan","year":"2019","unstructured":"Arslan B, G\u00f6n\u00fclta\u015f S, G\u00f6kmen E, \u00d6zman O, Avci MA, \u00d6zdemir E. Outcomes of intravesical chondroitin-sulfate and combined hyaluronic-acid\/chondroitin-sulfate therapy on female sexual function in bladder pain syndrome. Int Urogynecol J. 2019;30(11):1857\u201362.","journal-title":"Int Urogynecol J"},{"issue":"4","key":"559_CR51","doi-asserted-by":"publisher","first-page":"296","DOI":"10.5152\/tud.2018.63600","volume":"45","author":"H Sherif","year":"2018","unstructured":"Sherif H, Sebay A, Kandeel W, Othman T, Fathi A, Mohey A, Eshazly A. Safety and efficacy of Intravesical hyaluronic acid\/chondroitin sulfate in the treatment of refractory painful bladder syndrome. Turk J Urol. 2018;45(4):296\u2013301.","journal-title":"Turk J Urol"},{"key":"559_CR52","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejogrb.2020.10.060","volume":"256","author":"J Keane","year":"2021","unstructured":"Keane J, Young N, Goh J, Atherton M, Yin J, Moore K, Hall P, Higgs P, Leitch A, Lee J, Rosamilia A. A comparison of two intravesical bladder instillations for interstitial cystitis\/bladder pain syndrome. Eur J Obstet Gynecol Reprod Biol. 2021;256:230\u20134.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"559_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-020-04659-w","author":"XP Di","year":"2021","unstructured":"Di XP, Luo DY, Jin X, Zhao WY, Li H, Wang KJ. Efficacy and safety comparison of pharmacotherapies for interstitial cystitis and bladder pain syndrome: a systematic review and Bayesian network meta-analysis. Int Urogynecol J. 2021. https:\/\/doi.org\/10.1007\/s00192-020-04659-w. (Epub ahead of print).","journal-title":"Int Urogynecol J"},{"key":"559_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-020-04490-3","author":"S Liu","year":"2020","unstructured":"Liu S, Zhang C, Peng L, Lu Y, Luo D. Comparative effectiveness and safety of intravesical instillation treatment of interstitial cystitis\/bladder pain syndrome: a systematic review and network meta-analysis of randomized controlled trials. Int Urogynecol J. 2020. https:\/\/doi.org\/10.1007\/s00192-020-04490-3. (Epub ahead of print).","journal-title":"Int Urogynecol J"},{"issue":"4","key":"559_CR55","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00192-016-3079-4","volume":"28","author":"W Zhang","year":"2017","unstructured":"Zhang W, Deng X, Liu C, Wang X. Intravesical treatment for interstitial cystitis\/painful bladder syndrome: a network meta-analysis. Int Urogynecol J. 2017;28(4):515\u201325. https:\/\/doi.org\/10.1007\/s00192-016-3079-4.","journal-title":"Int Urogynecol J"},{"issue":"8","key":"559_CR56","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00192-015-2890-7","volume":"27","author":"JM Barua","year":"2016","unstructured":"Barua JM, Arance I, Angulo JC, Riedl CR. A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome\/interstitial cystitis. Int Urogynecol J. 2016;27(8):1137\u201347.","journal-title":"Int Urogynecol J"},{"issue":"4","key":"559_CR57","doi-asserted-by":"publisher","first-page":"447","DOI":"10.4081\/aiua.2022.4.447","volume":"94","author":"AF Ghaith","year":"2022","unstructured":"Ghaith AF, Radwan MH, Rashed Taha M, Elbendary MA, Al Damhogy ME, Hagras AM. Evaluation of pain and quality of life after hyaluronic acid instillation in addition to botulinum toxin-A injection in women with refractory Interstitial Cystitis\/Painful Bladder Syndrome: A pilot study. Arch Ital Urol Androl. 2022;94(4):447\u201350.","journal-title":"Arch Ital Urol Androl"},{"issue":"4","key":"559_CR58","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1159\/000447863","volume":"39","author":"JS Pyo","year":"2016","unstructured":"Pyo JS, Cho WJ. Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid\/Chondroitin Sulfate Instillation for Interstitial Cystitis\/Painful Bladder Syndrome. Cell Physiol Biochem. 2016;39(4):1618\u201325.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"559_CR59","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/nau.23284","volume":"37","author":"\u00d6 G\u00fclp\u0131nar","year":"2018","unstructured":"G\u00fclp\u0131nar \u00d6, Esen B, Kay\u0131\u015f A, G\u00f6k\u00e7e M\u0130, S\u00fcer E. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome\/interstitial cystitis. Neurourol Urodyn. 2018;37(1):257\u201362.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"559_CR60","first-page":"270","volume":"72","author":"M \u00d6zk\u0131d\u0131k","year":"2019","unstructured":"\u00d6zk\u0131d\u0131k M. Assessment of long-term intravesical hyaluronic acid, chondroitin sulfate and combination therapy for patients with bladder pain syndrome. Cent European J Urol. 2019;72(3):270\u20135.","journal-title":"Cent European J Urol"},{"issue":"4","key":"559_CR61","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nrurol.2010.23","volume":"7","author":"SG Smit","year":"2010","unstructured":"Smit SG, Heyns CF. Management of radiation cystitis. Nat Rev Urol. 2010;7(4):206\u201314.","journal-title":"Nat Rev Urol"},{"issue":"5","key":"559_CR62","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/0360-3016(94)00431-J","volume":"31","author":"LB Marks","year":"1995","unstructured":"Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 1995;31(5):1257\u201380.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"559_CR63","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1046\/j.1464-410X.2002.02813.x","volume":"90","author":"V Do","year":"2002","unstructured":"Do V, Choo R, Deboer G, Herschorn S, Danjoux C, Chen CH, Barak I. Urodynamic findings 3 months after radiotherapy in patients treated with conformal external beam radiotherapy for prostate carcinoma. BJU Int. 2002;90(1):62\u20137.","journal-title":"BJU Int"},{"issue":"2","key":"559_CR64","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1006\/gyno.1994.1278","volume":"55","author":"C Levenback","year":"1994","unstructured":"Levenback C, Eifel PJ, Burke TW, Morris M, Gershenson DM. Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol. 1994;55(2):206\u201310.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"559_CR65","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/j.1464-410X.2006.06491.x","volume":"98","author":"JG Blaivas","year":"2006","unstructured":"Blaivas JG, Weiss JP, Jones M. The pathophysiology of lower urinary tract symptoms after brachytherapy for prostate cancer. BJU Int. 2006;98(6):1233\u20137.","journal-title":"BJU Int"},{"issue":"2","key":"559_CR66","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0020-7292(98)00158-1","volume":"63","author":"HH Lin","year":"1998","unstructured":"Lin HH, Sheu BC, Lo MC, Huang SC. Abnormal urodynamic findings after radical hysterectomy or pelvic irradiation for cervical cancer. Int J Gynaecol Obstet. 1998;63(2):169\u201374.","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"559_CR67","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1464-410X.1988.tb06381.x","volume":"61","author":"DE Parkin","year":"1988","unstructured":"Parkin DE, Davis JA, Symonds RP. Urodynamic findings following radiotherapy for cervical carcinoma. Br J Urol. 1988;61(3):213\u20137.","journal-title":"Br J Urol"},{"key":"559_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.urology.2018.07.017","volume":"122","author":"N Lobo","year":"2018","unstructured":"Lobo N, Kulkarni M, Hughes S, Nair R, Khan MS, Thurairaja R. Urologic complications following pelvic radiotherapy. Urology. 2018;122:1\u20139.","journal-title":"Urology"},{"issue":"5","key":"559_CR69","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.medcli.2013.07.015","volume":"143","author":"RH Martinez Rodriguez","year":"2014","unstructured":"Martinez Rodriguez RH, Bayona Arenas S, Ibarz SL. Tratamiento con \u00e1cido hialur\u00f3nico de la hematuria asociada a cistopat\u00eda r\u00e1dica [Hyaluronic acid instillation as treatment of haematuria due to radiation induced cystitis]. Med Clin (Barc). 2014;143(5):230\u20131.","journal-title":"Med Clin (Barc)"},{"issue":"2","key":"559_CR70","first-page":"145","volume":"62","author":"ML Sommariva","year":"2010","unstructured":"Sommariva ML, Sandri SD, Ceriani V. Efficacy of sodium hyaluronate in the management of chemical and radiation cystitis. Minerva Urol Nefrol. 2010;62(2):145\u201350.","journal-title":"Minerva Urol Nefrol"},{"issue":"5","key":"559_CR71","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1464-410X.2011.10550.x","volume":"109","author":"Y Shao","year":"2012","unstructured":"Shao Y, Lu GL, Shen ZJ. Comparison of intravesical hyaluronic acid instillation and hyperbaric oxygen in the treatment of radiation-induced hemorrhagic cystitis. BJU Int. 2012;109(5):691\u20134.","journal-title":"BJU Int"},{"issue":"7","key":"559_CR72","first-page":"328","volume":"58","author":"J Nordling","year":"2008","unstructured":"Nordling J, van Ophoven A. Intravesical glycosaminoglycan replenishment with chondroitin sulphate in chronic forms of cystitis. A multi-national, multi-centre, prospective observational clinical trial. Arzneimittelforschung. 2008;58(7):328\u201335.","journal-title":"Arzneimittelforschung"},{"issue":"1","key":"559_CR73","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00345-021-03837-9","volume":"40","author":"M Baboudjian","year":"2022","unstructured":"Baboudjian M, Fourmarier M, Clement C, Cherasse A, Graziana JP, Bentaleb Y, Rouscoff Y, Ducrocq S, Gondran-Tellier B, Saussine C. Intravesical instillation of high molecular weight sodium hyaluronate in radiation-induced cystitis: a prospective pilot study. World J Urol. 2022;40(1):141\u20136.","journal-title":"World J Urol"},{"issue":"15","key":"559_CR74","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12894-015-0046-1","volume":"7","author":"M Gacci","year":"2015","unstructured":"Gacci M, Saleh O, Giannessi C, Detti B, Livi L, Monteleone Pasquetti E, Masoni T, Finazzi Agro E, Li Marzi V, Minervini A, Carini M, Gravas S, Oelke M, Serni S. Sodium hyaluronate and chondroitin sulfate replenishment therapy can improve nocturia in men with post-radiation cystitis: results of a prospective pilot study. BMC Urol. 2015;7(15):65.","journal-title":"BMC Urol"},{"issue":"5","key":"559_CR75","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.clgc.2016.01.016","volume":"14","author":"M Gacci","year":"2016","unstructured":"Gacci M, Saleh O, Giannessi C, Chini T, Della Camera PA, Detti B, Livi L, Finazzi Agro E, Li Marzi V, Minervini A, Carini M, Oelke M, Gravas S, Serni S. Bladder Instillation Therapy With Hyaluronic Acid and Chondroitin Sulfate Improves Symptoms of Postradiation Cystitis: Prospective Pilot Study. Clin Genitourin Cancer. 2016;14(5):444\u20139.","journal-title":"Clin Genitourin Cancer"},{"key":"559_CR76","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1721727X1401200117","volume":"12","author":"ML Sommariva","year":"2014","unstructured":"Sommariva ML, Lazzeri M, Abrate A, Guazzoni G, Sandri S, Montorsi F. Intravesical Hyaluronic Acid and Chondroitin Sulphate Improve Symptoms and Quality of Life in Patients with Late Radiation Tissue Cystitis: An Investigative Pilot Study. Eur J Inflam. 2014;12:177\u201385.","journal-title":"Eur J Inflam"},{"issue":"7","key":"559_CR77","doi-asserted-by":"publisher","first-page":"344.e19","DOI":"10.1016\/j.urolonc.2022.02.013","volume":"40","author":"F Sanguedolce","year":"2022","unstructured":"Sanguedolce F, Meneghetti I, Bevilacqua G, Monta\u00f1o B, Mart\u00ednez C, Territo A, Bala\u00f1a J, Palou J, Breda A. Intravesical instillation with glycosaminoglycan replacement treatment in patients suffering radiation-induced haemorrhagic cystitis: When and which patients can benefit most from it? Urol Oncol. 2022;40(7):344.e19-344.e25.","journal-title":"Urol Oncol"},{"issue":"6","key":"559_CR78","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00192-010-1357-0","volume":"22","author":"MH Hazewinkel","year":"2011","unstructured":"Hazewinkel MH, Stalpers LJ, Dijkgraaf MG, Roovers JP. Prophylactic vesical instillations with 0.2% chondroitin sulfate may reduce symptoms of acute radiation cystitis in patients undergoing radiotherapy for gynecological malignancies. Int Urogynecol J. 2011;22(6):725\u201330.","journal-title":"Int Urogynecol J"},{"key":"559_CR79","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.euros.2021.01.016","volume":"26","author":"J Palou Redorta","year":"2021","unstructured":"Palou Redorta J, Sanguedolce F, Sancho Pardo G, Romancik M, Vittori G, Minervini A, Di Maida F, Lunik R, Colombo R, Serretta V, \u00c7etinel B, Bini V, Corradengo D, Lazzeri M. Multicentre International Study for the Prevention with iAluRil of Radio-induced Cystitis (MISTIC): A Randomised Controlled Study. Eur Urol Open Sci. 2021;26:45\u201354.","journal-title":"Eur Urol Open Sci"},{"key":"559_CR80","first-page":"1","volume":"6","author":"GK King","year":"2022","unstructured":"King GK, Goodes LM, Hartshorn C, Thavaseelan J, Jonescu S, Watts A, Rawlins M, Woodland P, Synnott EL, Barrett T, Hayne D, Boan P, Dunlop SA. Intravesical hyaluronic acid with chondroitin sulphate to prevent urinary tract infection after spinal cord injury. J Spinal Cord Med. 2022;6:1\u20137.","journal-title":"J Spinal Cord Med"},{"issue":"3","key":"559_CR81","doi-asserted-by":"publisher","first-page":"366.e1","DOI":"10.1016\/j.jpurol.2020.02.009","volume":"16","author":"N Cicek","year":"2020","unstructured":"Cicek N, Yildiz N, Alpay H. Intravesical hyaluronic acid treatment in recurrent urinary tract infections in children with spina bifida and neurogenic bladder. J Pediatr Urol. 2020;16(3):366.e1-366.e5.","journal-title":"J Pediatr Urol"},{"issue":"7","key":"559_CR82","doi-asserted-by":"publisher","first-page":"ofac245","DOI":"10.1093\/ofid\/ofac245","volume":"9","author":"A Dinh","year":"2022","unstructured":"Dinh A, Duran C, Hamami K, Afif M, Bonnet F, Donay JL, Lafaurie M, Chartier-Kastler E. Hyaluronic Acid and Chondroitin Sulphate Treatment for Recurrent Severe Urinary Tract Infections due to Multidrug-Resistant Gram-Negative Bacilli in a Patient With Multiple Sclerosis: Case Report and Literature Review. Open Forum Infect Dis. 2022;9(7):ofac245.","journal-title":"Open Forum Infect Dis"},{"issue":"14","key":"559_CR83","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1471-2490-14-64","volume":"13","author":"L Topazio","year":"2014","unstructured":"Topazio L, Miano R, Maurelli V, Gaziev G, Gacci M, Iacovelli V, Finazzi-Agr\u00f2 E. Could hyaluronic acid (HA) reduce Bacillus Calmette-Gu\u00e9rin (BCG) local side effects? Results of a pilot study. BMC Urol. 2014;13(14):64.","journal-title":"BMC Urol"},{"issue":"1","key":"559_CR84","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4081\/aiua.2018.1.11","volume":"90","author":"V Imperatore","year":"2018","unstructured":"Imperatore V, Creta M, Di Meo S, Buonopane R, Longo N, Fusco F, Spirito L, Imbimbo C, Mirone V. Intravesical administration of combined hyaluronic acid and chondroitin sulfate can improve symptoms in patients with refractory bacillus Calmette-Guerin-induced chemical cystitis: Preliminary experience with one-year follow-up. Arch Ital Urol Androl. 2018;90(1):11\u20134.","journal-title":"Arch Ital Urol Androl"},{"key":"559_CR85","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejogrb.2016.10.018","volume":"207","author":"M Torella","year":"2016","unstructured":"Torella M, Del Deo F, Grimaldi A, Iervolino SA, Pezzella M, Tammaro C, Gallo P, Rappa C, De Franciscis P, Colacurci N. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2016;207:125\u20138.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"559_CR86","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/SPV.0000000000000560","volume":"25","author":"MC Schiavi","year":"2019","unstructured":"Schiavi MC, Porpora MG, Vena F, Prata G, Sciuga V, D\u2019Oria O, Di Tucci C, Savone D, Aleksa N, Giannini A, Nusiner MP, Zullo MA, Muzii L, Benedetti PP. Orally Administered Combination of Hyaluronic Acid, Chondroitin Sulfate, Curcumin, and Quercetin in the Prevention of Postcoital Recurrent Urinary Tract Infections: Analysis of 98 Women in Reproductive Age After 6 Months of Treatment. Female Pelvic Med Reconstr Surg. 2019;25(4):309\u201312.","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"3","key":"559_CR87","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/pathophysiology29030028","volume":"29","author":"C Manfredi","year":"2022","unstructured":"Manfredi C, Spirito L, Calace FP, Balsamo R, Terribile M, Stizzo M, Romano L, Napolitano L, Califano G, Cirillo L, Fusco GM, Rosati C, Quattrone C, Sciorio C, Creta M, Longo N, De Sio M, Arcaniolo D. Oral Preparation of Hyaluronic Acid, Chondroitin Sulfate, Curcumin, and Quercetin (Ialuril\u00ae Soft Gels) for the Prevention of LUTS after Intravesical Chemotherapy. Pathophysiology. 2022;29(3):365\u2013437.","journal-title":"Pathophysiology"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-023-00559-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-023-00559-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-023-00559-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T12:04:52Z","timestamp":1705579492000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-023-00559-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["559"],"URL":"https:\/\/doi.org\/10.1007\/s40122-023-00559-1","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"14 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S\u0142awomir Poletajew is consultant to IBSA. Magdalena M. Brz\u00f3zka is employee of IBSA Poland. Wojciech Krajewski has nothing to disclose. Hubert Kamecki has nothing to disclose. \u0141ukasz Nyk has nothing to disclose. Piotr Kryst has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}